AURO-LEVETIRACETAM 250 levetiracetam 250 mg tablets Bottle

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

levetiracetam, Quantity: 250 mg

Commercializzato da:

Strides Pharma Science Pty Ltd

INN (Nome Internazionale):

Levetiracetam

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: purified talc; magnesium stearate; povidone; colloidal anhydrous silica; maize starch; titanium dioxide; hypromellose; indigo carmine; macrogol 4000

Via di somministrazione:

Oral

Confezione:

60, 30

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

It is indicated for:,? use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation,,? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME),and,? add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).

Dettagli prodotto:

Visual Identification: Blue, oval shaped, biconvex film-coated tablets debossed with a deep break line separating 'E' and '10' on one side and plain on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2011-12-23